RAIPUR CHHATTISGARH INDIA ..LATEST BUSINESS RELEASES ADD ON.....
Transasia Bio-Medicals, India’s No.1 In-vitro Diagnostic Company celebrates its 40th anniversary with the launch of its new hematology range in Raipur Posted On 24th May 2019 : Posted By VISHAL MEDIA
Transasia Bio-Medicals, India’s No.1 In-vitro Diagnostic Company celebrates its 40th anniversary with the launch of its new hematology range in Raipur
Backed by European R&D, the new international range will make world-class diagnostics affordable for the masses in Raipur and the nearby areas
Raipur, 24th May 2019 : On the occasion of its 40th anniversary, Transasia Bio-Medicals Ltd., India’s No. 1 Diagnostic Company, announced the launch of their international range of hematology analyzers. Backed by European R&D, the 3-Part Differential (3PD) to 5-Part Differential (5PD) fully automated hematology analyzers, reagents and controls are being introduced for the first time to Indian market.
Transasia introduced the range at a grand celebration on 12thMay, 2019 at HotelZone by the Park, Raipur. The event was attended by over 130 senior pathologists, biochemists and laboratory technologists from reputed institutes. Dr. Preet Kaur, Business Unit Head, at Transasia, introduced the instruments to Doctors and provided scientific insights.
Dr. RenukaGahine,Head of Pathology at Pandit Jawaharlal Nehru Government Medical College, launched H 360, Dr. Diwan, PathologistShriBalaji Hospital, launched H 560 andDr. AvilokitaSahu, owner of Sahu Diagnosticslaunched Elite 580. Transasia also recognized senior pathologists (Dr.Ramesh Ostwal, Consultant at Ganga Diagnostics Centre,Dr. (Maj.) Santosh Gupta, Lab Director at Suyash Multispecialty Hospital, Dr. Rajesh Agarwal,owner at AgarwalOnco Clinic, Dr. F.M. Patel, renowned histopathologist, Dr. DilipRathore, owner of Rathore Pathology, Dr. Vinay Tiwari, Director at Tiwari Clinical Lab and Dr. AlkaHarne, owner at Hitek Pathology) with the title of ‘Lifetime Contribution to Lab Medicine.’ Saurabh Gupta, Divisional Business Head, proposed the vote of thanks.
In his comments, Suresh Vazirani, Chairman & Managing Director, Transasia Bio-Medicals Ltd., said, “Today marks a milestone in our quest to make high quality diagnostics affordable for the masses in India. The range introduced in India is comparable to the best globally. It is a proud moment for all of us at Transasia and it is apt that this coincides with the completion of Transasia’s 40th anniversary celebration.These next-generation instruments include a number of features to help institutions, clinicians and laboratory technologists offer accurate diagnosis. Manufactured by ErbaLachema (100% owned subsidiary of Transasia) in Europe, the H 360, H 560 and ELite 580 hematology analyzers are widely used in the European & global market. Hematology analyzers are extensively used in patient & research settings to count &characterize blood cells for disease detection and monitoring.Basic analyzers return a complete blood count (CBC) with a three-part differential white blood cell (WBC) count. Sophisticated analyzers measure cell morphology and can detect small cell populations to diagnose rare blood conditions.”
About Transasia Bio-Medicals Ltd.:
Founded in 1979, Transasia Bio-Medicals Ltd., India’s Leading In-vitro Diagnostic Company offers products and solutions in Biochemistry, Hematology, Coagulation, ESR, Immunology, Urinalysis, Critical Care, Diabetes Management, Microbiology and Molecular Diagnostics. Transasia provides doctors and patients with reliable, affordable and innovative Medical Diagnostic Systems, with an impressive install base of above 65,000 equipment across India. It has a vast network of the more than 250 service engineers, 400+ sales and marketing team, 23 zonal offices and 350+ distributors. It is the first Indian company to manufacture and export blood analyzers and reagents, in the 1990s. Today, Transasia’s indigenous research has resulted in development of state of the art, ‘Make in India’ products and technologies, enabling its products to be among the best in the world. All along its journey spanning more than four decades, Transasia has been recognized for its commitment to healthcare. It has been conferred ‘The Economic Times Best Brands 2019’ award, ‘India Medical Device - Export Company of the Year’ and the ‘Global Growth Company-2014’ award by the World Economic Forum amongst many others. Headquartered in Mumbai, Transasia is a part of the global Transasia-Erba group. The group has spread its footprint across USA, UK, Germany, Czech Republic, France, Italy, Russia and Turkey through various acquisitions. Transasia-Erba Group’s production sites in India, Czech Republic and USA and R&D centres in France, UK, India and Czech Republic form a hub for indigenous manufacturing of world class deliverables. Today, the group serves millions across 100 countries. For further information, kindly visit www.erbamannheim.com
Above Business Release Sourced by Citiesbazar through VISHALMEDIA (P.R.Agency), Mobile 098266-23100, Email- email@example.com